Anup Majumdar - Concepedia

Author

Anup Majumdar

Also Known As

A MAJUMDAR, A Majumdar, A. K. Majumdar, A. Majumdar, A.K. Majumdar, Abhinandan Majumdar, Anup K Majumdar, Anup K. Majumdar, Anup Majumdar, Anurakti Majumdar

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Thomas Jefferson University Institute of Post Graduate Medical Education and Research Johnson & Johnson (United States)

About

Anup Majumdar is an author at United States Military Academy specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1K
2	Health Sciences	3	3	106
3	Engineering	1	1	11
4	Natural Sciences	1	1	127
5	Public Health	1	1	11

Anup Majumdar

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant Mats Bergström, Richard Hargreaves, H. Donald Burns, Biological Psychiatry Receptor OccupancyNeuroanatomyMedicineNeuropeptide ReceptorNeuroimaging	2004	198
Pharmacokinetics of Ertapenem in Healthy Young Volunteers Anup Majumdar, Donald G. Musson, Kimberly L Birk, Antimicrobial Agents and Chemotherapy	2002	146
Tolerability of Fosaprepitant and Bioequivalency to Aprepitant in Healthy Subjects Kenneth C. Lasseter, Jay J. Gambale, Bo Jin, The Journal of Clinical Pharmacology Drug SafetyOral Nk1 AntagonistOncologyHealthy SubjectsPreclinical Drug Evaluation	2007	132
Evaluation of Potential Inductive Effects of Aprepitant on Cytochrome P450 3A4 and 2C9 Activity Craig R. Shadle, Yih Lee, Anup Majumdar, The Journal of Clinical Pharmacology Healthy SubjectsImmunologyReceptor AntagonistPharmacotherapyPotential Inductive Effects	2004	127
Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers Anup Majumdar, Laura Howard, Michael R. Goldberg, The Journal of Clinical Pharmacology 125-Mg CapsuleFmc CapsulesPharmacological StudyGastrointestinal PharmacologyMedicine	2006	99
Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe Anup Majumdar Clinical Pharmacology & Therapeutics	2003	99
Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin M. Depré, Anne Van Hecken, Merel Oeyen, European Journal of Clinical Pharmacology ThrombosisPharmacological StudyCardiovascular DiseasePharmacodynamicsMedicine	2005	65
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients Peter Nygren, Kenneth R. Hande, Kevin J. Petty, Cancer Chemotherapy and Pharmacology Molecular PharmacologyOncologyPharmacological StudyMedicineClinical Pharmacology	2005	65
Pharmacokinetics of Ertapenem in Patients With Varying Degrees of Renal Insufficiency and in Patients on Hemodialysis Goutam C. Mistry, Anup Majumdar, Suzanne K. Swan, The Journal of Clinical Pharmacology	2006	49
Multiple‐Dose Pharmacokinetics, Pharmacodynamics, and Safety of Taranabant, a Novel Selective Cannabinoid‐1 Receptor Inverse Agonist, in Healthy Male Volunteers Carol Addy, Paul Rothenberg, Susie Li, The Journal of Clinical Pharmacology Accumulation Half-lifePharmacotherapyMultiple-dose PharmacokineticsExperimental PharmacologyCannabinoid Pharmacology	2008	49

Page 1